Register or Sign in to Save this opportunity, or Send an Inquiry.
Cartexan® 400 Mg Hard Capsules - Chondroitin Sulfate
Bioiberica Spain flag Spain
Abstract ID:
Chondroitin Sulfate is indicated for the symptomatic treatment of osteoarthritis of the hip and knee.
Send an Inquiry
RE:
Participants
You
Description of Technology
• Cartexan 400 mg hard capsules contain chondroitin sulfate

•  Chondroitin Sulfate is indicated for the symptomatic treatment of osteoarthritis of the hip and knee.

• Currently authorized and commercialized as Rx in several countries of Europe (Finland, Austria, Hungary and Poland)

• CTD Dossier ready for registration.
Type of Business Relationship Sought
Available for out-licensing in Italy and Czech Republic.
FEATURED
Last Updated Feb 2018
Technology Type THERAPEUTIC
Phase of Development REGISTERED / FINISHED PRODUCT
CORPORATION

Opportunity Contact


Warning: include(js_message_scripts_n2.php) [function.include]: failed to open stream: No such file or directory in /home/pharmalicensing/public_html/detail.php on line 833

Warning: include() [function.include]: Failed opening 'js_message_scripts_n2.php' for inclusion (include_path='.:/usr/lib/php:/usr/local/lib/php') in /home/pharmalicensing/public_html/detail.php on line 833